Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.91
ABC's Cash to Debt is ranked higher than
71% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.62 vs. ABC: 0.91 )
ABC' s 10-Year Cash to Debt Range
Min: 0.07   Max: 1.38
Current: 0.91

0.07
1.38
Equity to Asset 0.09
ABC's Equity to Asset is ranked lower than
57% of the 61 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. ABC: 0.09 )
ABC' s 10-Year Equity to Asset Range
Min: -0.16   Max: 0.38
Current: 0.09

-0.16
0.38
Interest Coverage 10.02
ABC's Interest Coverage is ranked higher than
62% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.02 vs. ABC: 10.02 )
ABC' s 10-Year Interest Coverage Range
Min: 1.87   Max: 60.07
Current: 10.02

1.87
60.07
F-Score: 6
Z-Score: 6.36
M-Score: -2.58
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 0.65
ABC's Operating margin (%) is ranked higher than
50% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.73 vs. ABC: 0.65 )
ABC' s 10-Year Operating margin (%) Range
Min: 0.65   Max: 2.09
Current: 0.65

0.65
2.09
Net-margin (%) 0.23
ABC's Net-margin (%) is ranked higher than
50% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. ABC: 0.23 )
ABC' s 10-Year Net-margin (%) Range
Min: 0.22   Max: 0.92
Current: 0.23

0.22
0.92
ROE (%) 12.97
ABC's ROE (%) is ranked higher than
76% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.14 vs. ABC: 12.97 )
ABC' s 10-Year ROE (%) Range
Min: 6.14   Max: 102.56
Current: 12.97

6.14
102.56
ROA (%) 1.37
ABC's ROA (%) is ranked higher than
52% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.17 vs. ABC: 1.37 )
ABC' s 10-Year ROA (%) Range
Min: 1.37   Max: 4.8
Current: 1.37

1.37
4.8
ROC (Joel Greenblatt) (%) 91.41
ABC's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 25.75 vs. ABC: 91.41 )
ABC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 20.87   Max: 184.06
Current: 91.41

20.87
184.06
Revenue Growth (3Y)(%) 20.80
ABC's Revenue Growth (3Y)(%) is ranked higher than
88% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. ABC: 20.80 )
ABC' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 28.5
Current: 20.8

0
28.5
EBITDA Growth (3Y)(%) -5.20
ABC's EBITDA Growth (3Y)(%) is ranked lower than
52% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.20 vs. ABC: -5.20 )
ABC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 27
Current: -5.2

0
27
EPS Growth (3Y)(%) -21.60
ABC's EPS Growth (3Y)(%) is ranked lower than
56% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.30 vs. ABC: -21.60 )
ABC' s 10-Year EPS Growth (3Y)(%) Range
Min: -21.6   Max: 36.2
Current: -21.6

-21.6
36.2
» ABC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

ABC Guru Trades in Q4 2013

Steven Cohen 24,457 sh (+59.67%)
Jim Simons Sold Out
Joel Greenblatt Sold Out
Larry Robbins Sold Out
John Keeley 89,490 sh (-2.58%)
Ken Fisher 189,305 sh (-29.02%)
Jeremy Grantham 76,832 sh (-78.26%)
Ray Dalio 5,289 sh (-88.47%)
» More
Q1 2014

ABC Guru Trades in Q1 2014

Louis Moore Bacon 6,132 sh (New)
Paul Tudor Jones 13,509 sh (New)
Joel Greenblatt 6,078 sh (New)
Ray Dalio 29,089 sh (+449.99%)
Ken Fisher 183,543 sh (-3.04%)
John Keeley 77,330 sh (-13.59%)
Steven Cohen 16,574 sh (-32.23%)
Jeremy Grantham 38,500 sh (-49.89%)
» More
Q2 2014

ABC Guru Trades in Q2 2014

Jim Simons 5,200 sh (New)
Ken Fisher 183,657 sh (+0.06%)
Paul Tudor Jones Sold Out
Jeremy Grantham Sold Out
Joel Greenblatt Sold Out
Ray Dalio Sold Out
Louis Moore Bacon Sold Out
John Keeley 76,984 sh (-0.45%)
» More
Q3 2014

ABC Guru Trades in Q3 2014

Jim Simons 359,800 sh (+6819.23%)
John Keeley 76,100 sh (-1.15%)
Ken Fisher 169,692 sh (-7.6%)
» More
» Details

Insider Trades

Latest Guru Trades with ABC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ray Dalio 2014-06-30 Sold Out 0.02%$62.83 - $73.66 $ 91.6834%0
Joel Greenblatt 2014-06-30 Sold Out 0.01%$62.83 - $73.66 $ 91.6834%0
Ray Dalio 2014-03-31 Add 449.99%0.01%$64.11 - $71.38 $ 91.6835%29089
Joel Greenblatt 2014-03-31 New Buy0.01%$64.11 - $71.38 $ 91.6835%6078
Ray Dalio 2013-12-31 Reduce -88.47%0.02%$61.19 - $70.89 $ 91.6836%5289
Ken Fisher 2013-12-31 Reduce -29.02%0.01%$61.19 - $70.89 $ 91.6836%189305
Joel Greenblatt 2013-12-31 Sold Out 0.01%$61.19 - $70.89 $ 91.6836%0
Joel Greenblatt 2013-09-30 Reduce -95.6%0.18%$54.83 - $62.23 $ 91.6857%3543
John Keeley 2013-09-30 Reduce -24.14%0.03%$54.83 - $62.23 $ 91.6857%91863
Ray Dalio 2013-09-30 Add 65.99%0.01%$54.83 - $62.23 $ 91.6857%45889
John Hussman 2013-06-30 Sold Out 0.19%$51.64 - $56.3 $ 91.6869%0
Ray Dalio 2013-06-30 Reduce -58.27%0.02%$51.64 - $56.3 $ 91.6869%27645
John Hussman 2013-03-31 New Buy0.19%$43.18 - $51.45 $ 91.6896%100000
John Keeley 2013-03-31 New Buy0.14%$43.18 - $51.45 $ 91.6896%139667
Joel Greenblatt 2013-03-31 Reduce -22.53%0.07%$43.18 - $51.45 $ 91.6896%92842
Ray Dalio 2013-03-31 Reduce -39.33%0.02%$43.18 - $51.45 $ 91.6896%66255
John Keeley 2012-12-31 Sold Out 0.16%$39.03 - $43.91 $ 91.68123%0
Ray Dalio 2012-12-31 Reduce -46.47%0.05%$39.03 - $43.91 $ 91.68123%109210
Ken Fisher 2012-12-31 Add 72.83%0.01%$39.03 - $43.91 $ 91.68123%218669
Chris Davis 2012-12-31 Sold Out 0.0015%$39.03 - $43.91 $ 91.68123%0
Andreas Halvorsen 2012-09-30 Sold Out 0.6%$37.36 - $39.78 $ 91.68137%0
John Keeley 2012-09-30 Reduce -65.63%0.32%$37.36 - $39.78 $ 91.68137%185401
Ken Fisher 2012-09-30 New Buy0.01%$37.36 - $39.78 $ 91.68137%126520
Chris Davis 2012-09-30 New Buy$37.36 - $39.78 $ 91.68137%943
John Keeley 2012-06-30 Reduce -26.38%0.16%$35.7 - $39.61 $ 91.68146%539491
Andreas Halvorsen 2012-06-30 Add 33.16%0.15%$35.7 - $39.61 $ 91.68146%1875500
Ray Dalio 2012-06-30 Reduce -24.62%0.05%$35.7 - $39.61 $ 91.68146%248910
Andreas Halvorsen 2012-03-31 Add 729.02%0.4%$36.19 - $40.09 $ 91.68158%1408500
Joel Greenblatt 2012-03-31 Add 76.09%0.19%$36.19 - $40.09 $ 91.68158%128834
John Keeley 2012-03-31 Reduce -25.12%0.19%$36.19 - $40.09 $ 91.68158%732766
Ray Dalio 2012-03-31 Add 103.82%0.1%$36.19 - $40.09 $ 91.68158%330210
Joel Greenblatt 2011-12-31 Add 106.08%0.17%$35.57 - $42.08 $ 91.68142%73162
Ray Dalio 2011-12-31 New Buy0.1%$35.57 - $42.08 $ 91.68142%162010
Andreas Halvorsen 2011-12-31 New Buy0.07%$35.57 - $42.08 $ 91.68142%169900
Joel Greenblatt 2011-09-30 Add 23.76%0.04%$34.63 - $43.09 $ 91.68134%35502
Ray Dalio 2011-09-30 Sold Out 0.01%$34.63 - $43.09 $ 91.68134%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 79.20
ABC's P/E(ttm) is ranked higher than
58% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 25.80 vs. ABC: 79.20 )
ABC' s 10-Year P/E(ttm) Range
Min: 11.12   Max: 79.63
Current: 79.2

11.12
79.63
P/B 10.50
ABC's P/B is ranked higher than
54% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.90 vs. ABC: 10.50 )
ABC' s 10-Year P/B Range
Min: 1.24   Max: 10.57
Current: 10.5

1.24
10.57
P/S 0.20
ABC's P/S is ranked higher than
93% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.91 vs. ABC: 0.20 )
ABC' s 10-Year P/S Range
Min: 0.09   Max: 0.2
Current: 0.2

0.09
0.2
PFCF 17.80
ABC's PFCF is ranked higher than
86% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 48.12 vs. ABC: 17.80 )
ABC' s 10-Year PFCF Range
Min: 3.51   Max: 50.58
Current: 17.8

3.51
50.58
EV-to-EBIT 25.89
ABC's EV-to-EBIT is ranked higher than
66% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.79 vs. ABC: 25.89 )
ABC' s 10-Year EV-to-EBIT Range
Min: 6.6   Max: 28.1
Current: 25.89

6.6
28.1
Shiller P/E 42.90
ABC's Shiller P/E is ranked higher than
70% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.62 vs. ABC: 42.90 )
ABC' s 10-Year Shiller P/E Range
Min: 13.76   Max: 43.09
Current: 42.9

13.76
43.09
Current Ratio 0.97
ABC's Current Ratio is ranked lower than
58% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. ABC: 0.97 )
ABC' s 10-Year Current Ratio Range
Min: 0.97   Max: 1.46
Current: 0.97

0.97
1.46
Quick Ratio 0.48
ABC's Quick Ratio is ranked lower than
60% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.13 vs. ABC: 0.48 )
ABC' s 10-Year Quick Ratio Range
Min: 0.43   Max: 0.7
Current: 0.48

0.43
0.7

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.10
ABC's Dividend Yield is ranked lower than
74% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. ABC: 1.10 )
ABC' s 10-Year Dividend Yield Range
Min: 0.11   Max: 1.44
Current: 1.1

0.11
1.44
Dividend Payout 0.78
ABC's Dividend Payout is ranked higher than
56% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.72 vs. ABC: 0.78 )
ABC' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.8
Current: 0.78

0.03
0.8
Dividend growth (3y) 29.80
ABC's Dividend growth (3y) is ranked higher than
87% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.90 vs. ABC: 29.80 )
ABC' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 81.7
Current: 29.8

0
81.7
Yield on cost (5-Year) 4.51
ABC's Yield on cost (5-Year) is ranked higher than
68% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.72 vs. ABC: 4.51 )
ABC' s 10-Year Yield on cost (5-Year) Range
Min: 0.45   Max: 5.9
Current: 4.51

0.45
5.9
Share Buyback Rate 5.40
ABC's Share Buyback Rate is ranked higher than
96% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.20 vs. ABC: 5.40 )
ABC' s 10-Year Share Buyback Rate Range
Min: 10   Max: -30.6
Current: 5.4

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.50
ABC's Price/DCF (Projected) is ranked higher than
75% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.49 vs. ABC: 1.50 )
ABC' s 10-Year Price/DCF (Projected) Range
Min: 0.63   Max: 2.9
Current: 1.5

0.63
2.9
Price/Median PS Value 1.40
ABC's Price/Median PS Value is ranked higher than
65% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.33 vs. ABC: 1.40 )
ABC' s 10-Year Price/Median PS Value Range
Min: 0.73   Max: 2.08
Current: 1.4

0.73
2.08
Earnings Yield (Greenblatt) 3.90
ABC's Earnings Yield (Greenblatt) is ranked higher than
63% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.80 vs. ABC: 3.90 )
ABC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.6   Max: 15.2
Current: 3.9

3.6
15.2
Forward Rate of Return (Yacktman) 5.76
ABC's Forward Rate of Return (Yacktman) is ranked higher than
52% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.55 vs. ABC: 5.76 )
ABC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 5.7   Max: 31.8
Current: 5.76

5.7
31.8

Analyst Estimate

Sep15 Sep16 Sep17
Revenue(Mil) 126,354 131,433 138,033
EPS($) 4.45 5.04 5.67
EPS without NRI($) 4.45 5.04 5.67

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:MCK, CAH, SHTDF, HSIC, PDCO » details
Traded in other countries:ABG.Germany,
AmerisourceBergen Corp is a Delaware Corporation and was formed in 2001. It is a pharmaceutical services company, with operations mainly in the United States and Canada. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, it provides drug distribution and related services designed to reduce costs and improve patient outcomes. The Company distributes a comprehensive offering of brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers mainly located in the United States and Canada, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, long-term care and other alternate site pharmacies, and other customers. The Company also provides pharmacy services to certain specialty drug patients. Additionally, it furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services, including pharmaceutical packaging, pharmacy automation, inventory management, reimbursement and pharmaceutical consulting services, logistics services, and pharmacy management. It currently serves its customers (healthcare providers, pharmaceutical manufacturers, and certain specialty drug patients) through a geographically diverse network of distribution service centers and other operations in the United States and Canada, and through packaging facilities in the United States and the United Kingdom. The Company's national competitors are Cardinal Health, Inc. (Cardinal) and McKesson Corporation (McKesson). It is subject to oversight by various federal and state governmental entities and it is subject to, and affected by, a variety of federal and state laws, regulations and policies.
» More Articles for ABC

Headlines

Articles On GuruFocus.com
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
Dividend Aristocrats In Focus Part 26 of 54: Walgreens Oct 23 2014 
AmerisourceBergen Is a Center Piece in the Pharma Industry Sep 30 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
Weekly CEO Sells Highlight: AmerisourceBergen, Huntsman, Johnson Controls, Cigna, and Foster Wheeler Jun 15 2014 
Graham Holdings Taking Care of the Business Apr 11 2014 
Cardinal Health Inc. Dividend Stock Analysis Dec 13 2013 
Why Am I Staying Bullish on Walgreen? Nov 20 2013 
Quality, Capital Allocation, Value and Growth Aug 03 2013 


More From Other Websites
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014
AMERISOURCEBERGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Dec 08 2014
Next week's game plan: Agios & United Tech Dec 05 2014
AMERISOURCEBERGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers Dec 05 2014
AMERISOURCEBERGEN CORP Financials Dec 02 2014
Some Big Cap 20 Names Holding Up In Monday's Sell-Off Dec 01 2014
10-K for AmerisourceBergen Corp. Nov 27 2014
AMERISOURCEBERGEN CORP Files SEC form 10-K, Annual Report Nov 25 2014
Roche's Genentech defends supply shift for top cancer drugs Nov 24 2014
From Acquired To Leading the Acquirer: Stewart McCutcheon's Journey At Ecolab Nov 24 2014
Care Fusion & Becton, Dickinson Hit Highs on Merger Progress Nov 24 2014
Asia Bio-Chem Group Corp. Announces Third Quarter 2014 Financial Results Nov 21 2014
Asia Bio-Chem Group Corp. Announces Third Quarter 2014 Financial Results Nov 21 2014
AmerisourceBergen downgraded by FBR Capital Nov 21 2014
Cramer: Don't let skepticism run away with you Nov 19 2014
Today's quick look at the Market... Nov 17 2014
AmerisourceBergen Reports Fourth Quarter and Fiscal Year 2014 Results Nov 11 2014
Big Cap 20 Stuffed With Medical Names Nov 10 2014
Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Announces Investigation of AmerisourceBergen... Nov 10 2014
Why AmerisourceBergen (ABC) Could Be a Top Value Stock Pick Nov 10 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK